Determination of the PI3K alpha selective inhibitor alpelisib mechanism of action and efficacy in ER+/ PIK3CA mutant breast cancer preclinical models
- Resource Type
- Journal
- Source
CANCER RESEARCH ; JUL 2018, 78 13, 1p. Supplement: S- Subject
- Language
- English
- ISSN
- 15387445